Orville G. Kolterman
Directeur/Bestuurslid bij American Diabetes Association Research Foundation, Inc.
Actieve functies van Orville G. Kolterman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| National Institute of Diabetes & Digestive & Kidney Diseases | Corporate Officer/Principal | - | - |
GlySens, Inc.
 GlySens, Inc. Medical SpecialtiesHealth Technology GlySens, Inc. develops glucose monitoring system. It offers GlySens ICGM system, a long continuous glucose monitoring system intends to dramatically improve the lives of people with diabetes. The firm develops testing in clinical trials a novel, long term implant to continuously monitor and transmit blood glucose levels to smart phones and other devices. The company was founded by Joseph Y. Lucisano and David A. Gough in 1998 and is headquartered in San Diego, CA. | Directeur/Bestuurslid | 27-10-2011 | - |
| American Diabetes Association Research Foundation, Inc. | Directeur/Bestuurslid | 27-10-2011 | - |
Loopbaan van Orville G. Kolterman
Eerdere bekende functies van Orville G. Kolterman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Directeur/Bestuurslid | - | 29-01-2019 |
| University of California San Diego | Corporate Officer/Principal | 01-01-1983 | 01-01-1992 |
| The University of Colorado School of Medicine | Corporate Officer/Principal | 01-01-1978 | 01-01-1983 |
American Diabetes Association
 American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | President | - | - |
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Hoofd Techniek/Wetenschap/O&O | 01-01-1992 | - |
| Algemeen Adviseur | 01-01-1992 | - |
Opleiding van Orville G. Kolterman
| Stanford University School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 10 |
Operationeel
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 4 |
| Government | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
| National Institute of Diabetes & Digestive & Kidney Diseases | Government |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Commercial Services |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
GlySens, Inc.
GlySens, Inc. Medical SpecialtiesHealth Technology GlySens, Inc. develops glucose monitoring system. It offers GlySens ICGM system, a long continuous glucose monitoring system intends to dramatically improve the lives of people with diabetes. The firm develops testing in clinical trials a novel, long term implant to continuously monitor and transmit blood glucose levels to smart phones and other devices. The company was founded by Joseph Y. Lucisano and David A. Gough in 1998 and is headquartered in San Diego, CA. | Health Technology |
| American Diabetes Association Research Foundation, Inc. |
